Greenberg ML - Search Results

1

Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249.

Veazey RS, Ketas TA, Klasse PJ, Davison DK, Singletary M, Green LC, Greenberg ML, Moore JP. Veazey RS, et al. Among authors: greenberg ml. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10531-6. doi: 10.1073/pnas.0802666105. Epub 2008 Jul 22. Proc Natl Acad Sci U S A. 2008. PMID: 18647836 Free PMC article.

2

Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.

Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK. Dwyer JJ, et al. Among authors: greenberg ml. Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7. doi: 10.1073/pnas.0701478104. Epub 2007 Jul 19. Proc Natl Acad Sci U S A. 2007. PMID: 17640899 Free PMC article.

3

Impact of the enfuvirtide resistance mutation N43D and the associated baseline polymorphism E137K on peptide sensitivity and six-helix bundle structure.

Bai X, Wilson KL, Seedorff JE, Ahrens D, Green J, Davison DK, Jin L, Stanfield-Oakley SA, Mosier SM, Melby TE, Cammack N, Wang Z, Greenberg ML, Dwyer JJ. Bai X, et al. Among authors: greenberg ml. Biochemistry. 2008 Jun 24;47(25):6662-70. doi: 10.1021/bi702509d. Biochemistry. 2008. PMID: 18507398

4

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.

Sista PR, Melby T, Davison D, Jin L, Mosier S, Mink M, Nelson EL, DeMasi R, Cammack N, Salgo MP, Matthews TJ, Greenberg ML. Sista PR, et al. Among authors: greenberg ml. AIDS. 2004 Sep 3;18(13):1787-94. doi: 10.1097/00002030-200409030-00007. AIDS. 2004. PMID: 15316339 Clinical Trial.

5

Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro.

Mink M, Mosier SM, Janumpalli S, Davison D, Jin L, Melby T, Sista P, Erickson J, Lambert D, Stanfield-Oakley SA, Salgo M, Cammack N, Matthews T, Greenberg ML. Mink M, et al. Among authors: greenberg ml. J Virol. 2005 Oct;79(19):12447-54. doi: 10.1128/JVI.79.19.12447-12454.2005. J Virol. 2005. PMID: 16160172 Free PMC article.

6

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.

Tomaras GD, Lacey SF, McDanal CB, Ferrari G, Weinhold KJ, Greenberg ML. Tomaras GD, et al. Among authors: greenberg ml. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3503-8. doi: 10.1073/pnas.97.7.3503. Proc Natl Acad Sci U S A. 2000. PMID: 10725407 Free PMC article.

7

The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1.

Lacey SF, McDanal CB, Horuk R, Greenberg ML. Lacey SF, et al. Among authors: greenberg ml. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9842-7. doi: 10.1073/pnas.94.18.9842. Proc Natl Acad Sci U S A. 1997. PMID: 9275213 Free PMC article.

8

A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.

Cleghorn FR, Jack N, Carr JK, Edwards J, Mahabir B, Sill A, McDanal CB, Connolly SM, Goodman D, Bennetts RQ, O'Brien TR, Weinhold KJ, Bartholomew C, Blattner WA, Greenberg ML. Cleghorn FR, et al. Among authors: greenberg ml. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10532-7. doi: 10.1073/pnas.97.19.10532. Proc Natl Acad Sci U S A. 2000. PMID: 10984542 Free PMC article.

9

Resistance to enfuvirtide, the first HIV fusion inhibitor.

Greenberg ML, Cammack N. Greenberg ML, et al. J Antimicrob Chemother. 2004 Aug;54(2):333-40. doi: 10.1093/jac/dkh330. Epub 2004 Jul 1. J Antimicrob Chemother. 2004. PMID: 15231762 Review.

10

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

Eron JJ, Gulick RM, Bartlett JA, Merigan T, Arduino R, Kilby JM, Yangco B, Diers A, Drobnes C, DeMasi R, Greenberg M, Melby T, Raskino C, Rusnak P, Zhang Y, Spence R, Miralles GD. Eron JJ, et al. J Infect Dis. 2004 Mar 15;189(6):1075-83. doi: 10.1086/381707. Epub 2004 Mar 2. J Infect Dis. 2004. PMID: 14999611 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters